CD49f-positive cell population efficiently enriches colon cancer-initiating cells

International Journal of Oncology

Volumn 43, Issue 2, 2013, Pages 425-430

  Haraguchi, Naotsugu ^a   Ishii, Hideshi ^b   Mimori, Koshi ^c   Ohta, Katsuya ^a   Uemura, Mamoru ^a   Nishimura, Junichi ^a   Hata, Taishi ^a   Takemasa, Ichiro ^a   Mizushima, Tsunekazu ^a   Yamamoto, Hirofumi ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

Author keywords

CD44; CD49f; Colon cancer; Colon cancer initiating cells; Surface markers

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALKALINE PHOSPHATASE; ALPHA6 INTEGRIN; BUTYRIC ACID; CD133 ANTIGEN; CD24 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; HERMES ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENIC ACTIVITY; CELL ADHESION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL POPULATION; CELL RENEWAL; CELL STRAIN HT29; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ACTIVATED-LEUKOCYTE CELL ADHESION MOLECULE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD24; ANTIGENS, CD44; BUTYRIC ACID; CACO-2 CELLS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; COLONIC NEOPLASMS; GLYCOPROTEINS; HT29 CELLS; HUMANS; INTEGRIN ALPHA6; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; RECEPTORS, CXCR4; TUMOR MARKERS, BIOLOGICAL;

EID: 84879632446     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1955     Document Type: Article

References (36)

1. Lapidot T, Sirard C, Vormoor J, et al: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645-648, 1994. (Pubitemid 24067706)
2. Singh SK, Hawkins C, Clarke ID, et al: Identification of human brain tumour initiating cells. Nature 432: 396-401, 2004. (Pubitemid 39551674)
3. Kim CF, Jackson EL, Woolfenden AE, et al: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835, 2005. (Pubitemid 40806415)
4. Pardal R, Clarke MF and Morrison SJ: Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3: 895-902, 2003. (Pubitemid 37500174)
5. O'Brien CA, Pollett A, Gallinger S and Dick JE: A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106-110, 2007. (Pubitemid 46067310)
6. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C and De Maria R: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007. (Pubitemid 46067311)
7. Ieta K, Tanaka F, Haraguchi N, et al: Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol 15: 638-648, 2007.
8. Dalerba P, Dylla SJ, Park IK, et al: Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 104: 10158-10163, 2007. (Pubitemid 47175279)
9. Vermeulen L, Todaro M, de Sousa Mello F, et al: Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci USA 105: 13427-13432, 2008.
10. Huang EH, Hynes MJ, Zhang T, et al: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389, 2009.
11. Todaro M, Francipane MG, Medema JP and Stassi G: Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162, 2010.
12. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1: 313-323, 2007. (Pubitemid 47355323)
13. Liu R, Wang X, Chen GY, et al: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217-226, 2007. (Pubitemid 46143225)
14. Pang R, Law WL, Chu AC, et al: A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 6: 603-615, 2010.
15. Cordenonsi M, Zanconato F, Azzolin L, et al: The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147: 759-772, 2011.
16. Kitayama J, Nagawa H, Tsuno N, et al: Laminin mediates tethering and spreading of colon cancer cells in physiological shear flow. Br J Cancer 80: 1927-1934, 1999. (Pubitemid 29391276)
17. Daemi N, Thomasset N, Lissitzky JC, et al: Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression. Int J Cancer 85: 850-856, 2000. (Pubitemid 30131477)
18. Enns A, Gassmann P, Schlüter K, Korb T, Spiegel HU, Senninger N and Haier J: Integrins can directly mediate metastatic tumor cell adhesion within the liver sinusoids. J Gastrointest Surg 8: 1049-1059, 2004.
19. Dydensborg AB, Teller IC, Groulx JF, et al: Integrin alpha6Bbeta4 inhibits colon cancer cell proliferation and c-Myc activity. BMC Cancer 9: 223, 2009.
20. Sakthianandeswaren A, Christie M, D'Andreti C, et al: PHLDA1 expression marks the putative epithelial stem cells and contributes to intestinal tumorigenesis. Cancer Res 71: 3709-3719, 2011.
21. Robertson JH, Yang SY, Winslet MC and Seifalian AM: Functional blocking of specific integrins inhibit colonic cancer migration. Clin Exp Metastasis 26: 769-780, 2009.
22. Vanharanta S, Shu W, Brenet F, et al: Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat Med 19: 50-56, 2013.
23. Wu B, Chien EY, Mol CD, et al: Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330: 1066-1071, 2010.
24. Murphy PM: Chemokines and the molecular basis of cancer metastasis. N Engl J Med 345: 833-835, 2001.
25. Liotta LA: An attractive force in metastasis. Nature 410: 24-25, 2001.
26. Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
27. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K and Miyazono K: Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5: 504-514, 2009.
28. Piccirillo SG, Reynolds BA, Zanetti N, et al: Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444: 761-765, 2006. (Pubitemid 44949605)
29. Chirasani SR, Sternjak A, Wend P, et al: Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cells. Brain 133: 1961-1972, 2010.
30. Lombardo Y, Scopelliti A, Cammareri P, et al: Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140: 297-309, 2011.
31. Haraguchi N, Ohkuma M, Sakashita H, et al: 133+CD44+ population efficiently enriches colon cancer initiating cells. Ann Surg Oncol 15: 2927-2933, 2008.
32. Sussman NL, Eliakim R, Rubin D, Perlmutter DH, DeSchryver-Kecskemeti K and Alpers DH: Intestinal alkaline phosphatase is secreted bidirectionally from villous enterocytes. Am J Physiol 257: G14-G23, 1989.
33. Augeron C and Laboisse CL: Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 44: 3961-3969, 1984. (Pubitemid 14041623)
34. Jo M, Eastman BM, Webb DL, Stoletov K, Klemke R and Gonias SL: Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells. Cancer Res 70: 8948-8958, 2010.
35. Liao CP, Adisetiyo H, Liang M and Roy-Burman P: Cancer-associated fibroblasts enhance the gland-forming capability of prostate cancer stem cells. Cancer Res 70: 7294-7303, 2010.
36. Lathia JD, Gallagher J, Heddleston JM, et al: Integrin alpha 6 regulates glioblastoma stem cells. Stem Cell 6: 421-432, 2010.